anilinocarbonylmethylsulfonylchloride | 159215-12-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: anilinocarbonylmethylsulfonylchloride
• 英文别名: (Phenylcarbamoyl)methanesulfonyl chloride；2-anilino-2-oxoethanesulfonyl chloride
• CAS: 159215-12-0
• 化学式: C₈H₈ClNO₃S
• mdl: MFCD19200956
• 分子量: 233.675
• InChiKey: RGNGTAQLFUHOTI-UHFFFAOYSA-N

物化性质

• 沸点：
  442.6±28.0 °C(Predicted)
• 密度：
  1.508±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  71.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  anilinocarbonylmethylsulfonylchloride 在 potassium phosphate 、 碘苯二乙酸 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 水 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 3.0h， 生成 2-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-N-phenyl-1,2-thiazinane-6-carboxamide 1,1-dioxide
  参考文献：
  名称：

  Discovery of novel type II c-Met inhibitors based on BMS-777607

  摘要：

  Twenty-two new analogs based on the structure of BMS-777607 were designed, synthesized, and evaluated to determine their biological activities. Compounds bearing a cyclic sulfonamide or α-chloropiperidone scaffold exhibited good activity, which may provide a new basis for further structural optimization. Quinoline-containing analogs exhibited better results than did their counterparts with an aminopyrimidine, aminopyridine, or pyrrolopyridine unit. Two analogs, 22d and 22e, stood out as the most potent c-Met inhibitors with IC50s of 0.9 and 1.7 nM, respectively. These two compounds were more potent than BMS-777607 in enzymatic inhibition and cell proliferation studies.

  DOI：

  10.1016/j.ejmech.2014.04.056
• 作为产物：
  描述：

  苯胺 在 三乙胺 、 sodium sulfite 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 5.0h， 生成 anilinocarbonylmethylsulfonylchloride
  参考文献：
  名称：

  Discovery of novel type II c-Met inhibitors based on BMS-777607

  摘要：

  Twenty-two new analogs based on the structure of BMS-777607 were designed, synthesized, and evaluated to determine their biological activities. Compounds bearing a cyclic sulfonamide or α-chloropiperidone scaffold exhibited good activity, which may provide a new basis for further structural optimization. Quinoline-containing analogs exhibited better results than did their counterparts with an aminopyrimidine, aminopyridine, or pyrrolopyridine unit. Two analogs, 22d and 22e, stood out as the most potent c-Met inhibitors with IC50s of 0.9 and 1.7 nM, respectively. These two compounds were more potent than BMS-777607 in enzymatic inhibition and cell proliferation studies.

  DOI：

  10.1016/j.ejmech.2014.04.056

文献信息

• Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of .BETA.-lactamases.
  作者：SOPHIE VANWETSWINKEL、JACOQUES FASTREZ、JACQUELINE MARCHAND-BRYNAERT

  DOI：10.7164/antibiotics.47.1041

  日期：——

  Three new sulfonylamido-penicillanic acid sulfones have been prepared by reaction of 6-aminopenicillanic esters with the monoester or monoamide derivatives obtained in nucleophilic substitution reactions by alcohol or aniline on the carboxyl chloride function of sulfoacetic dichloride followed by oxidation. These penicillin sulfones are converted to beta-lactamases suicide inhibitors by removal of

  通过使6-氨基青霉酸酯与在亲核取代反应中通过醇或苯胺获得的单酯或单酰胺衍生物对磺基乙酸二氯化物的羧氯官能团进行反应，然后进行氧化，制备了三种新的磺酰氨基-戊二酸砜。通过除去C3酯保护基，将这些青霉素砜转化为β-内酰胺酶自杀抑制剂。这种合成策略可以使带有各种6-氨基侧链的磺酰胺基戊酰胺砜得到使用。这些抑制剂可迅速使RTEMβ-内酰胺酶失活。失活的动力学与酰基辅酶中间体在两个主要途径之间的分配是一致的：游离酶的再生和不可逆的失活，观察到很少的瞬时失活。
• Pyrrole Derivatives As Pharmaceutical Agents
  申请人：Canne Bannen Lynne

  公开号：US20080234270A1

  公开（公告）日：2008-09-25

  Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.

  提供了用于调节受体活性的化合物、组合物和方法。特别提供了用于调节受体活性的化合物和组合物，以及用于治疗、预防或改善与受体活性直接或间接相关的一种或多种疾病或紊乱的症状的方法。
• Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands
  申请人：Flatt Brenton T.

  公开号：US20110144128A1

  公开（公告）日：2011-06-16

  Heterocyclic carboxamide compounds are described herein as being useful in modulating the activity of steroid nuclear receptors. Pharmaceutical compositions containing the compounds, methods of using the compounds and processes for making the compounds are also described.

  本文介绍了杂环羧酰胺化合物作为调节类固醇核受体活性的有用物质。还描述了含有这些化合物的制药组合物，使用这些化合物的方法以及制造这些化合物的过程。
• PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS
  申请人：Exelixis, Inc.

  公开号：EP1773768B1

  公开（公告）日：2018-08-22
• EP1773768A4
  申请人：——

  公开号：EP1773768A4

  公开（公告）日：2008-08-06